A Multiple-Dose, Single Period, Phase II Dose Ranging Study to Examine Testagen® TDS-Testosterone 5% in Adult Male Subjects
Phase of Trial: Phase II
Latest Information Update: 10 May 2019
Price : $35 *
At a glance
- Drugs Testosterone (Primary) ; Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics; Registrational
- Acronyms PARC-T-D
- Sponsors Transdermal Delivery Solutions Corp
- 08 May 2019 Planned End Date changed from 1 Mar 2019 to 1 Mar 2021.
- 08 May 2019 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2020.
- 31 Aug 2018 Biomarkers information updated